The impact of low-grade toxicity in older people with cancer undergoing chemotherapy
Authors:
Open Access
- 30 September 2014
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 111 (12) , 2224-2228
Abstract
Significant toxicity in chemotherapy trials is usually defined as grade 3. In clinical practice, however, multiple lower grade toxicities are often considered meaningful. The purpose of this observational cohort study was to identify which level of toxicity triggers treatment modification and early discontinuation of chemotherapy in older people. Patients aged 65+ were recruited in a central London hospital. A total of 108 patients were recruited at the start of new chemotherapy treatment between October 2010 and July 2012. Mean age was 72.1±5 years, median 72 and range 65–86 years. Of the patients, 50.9% (55) were male with gastrointestinal (49), gynaecological (18), lung (15) and other cancers (26). Chemotherapy was palliative in 59.3% (64/108), curative/ neoadjuvant/adjuvant in the others. Mean number of cycles completed was 4.2±3. Treatment modifications due to toxicity occurred in 60 (55.6%) patients, 35% (21/60) of whom had no greater than grade 2 toxicity. Early treatment discontinuation because of toxicity occurred in 23 patients (21.3%), 39.1% (9/23) of whom had no greater than grade 2 toxicity. Many older patients did not complete treatment as planned. Treatment was modified/discontinued even for one or two low-grade toxicities. Further work is required to clarify whether low-grade toxicity has a greater clinical impact in older people, or whether clinicians have a lower threshold for modifying/discontinuing treatment in older people.Keywords
This publication has 37 references indexed in Scilit:
- Uptake and Tolerance of Chemotherapy in Elderly Patients with Small Cell Lung Cancer and Impact on SurvivalJournal of Cancer Epidemiology, 2012
- Quimioterapia sistémica basada en docetaxel en hombres coreanos mayores con cáncer de próstata resistente a la castraciónActas Urológicas Españolas, 2012
- Review article: benefits and risks of chemotherapy in elderly patients with metastatic colorectal cancerAlimentary Pharmacology & Therapeutics, 2008
- Overcoming challenges associated with chemotherapy treatment in the senior adult populationCritical Reviews in Oncology/Hematology, 2008
- Does a Geriatric Oncology Consultation Modify the Cancer Treatment Plan for Elderly Patients?The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2008
- Identifying Vulnerable Older Adults with Cancer: Integrating Geriatric Assessment into Oncology PracticeJournal of the American Geriatrics Society, 2007
- A pilot study of the vulnerable elders survey‐13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablationCancer, 2007
- Can older cancer patients tolerate chemotherapy?Cancer, 2003
- Comprehensive Assessment of the Elderly Cancer Patient: The Feasibility of Self-Report MethodologyJournal of Clinical Oncology, 2002
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993